These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1599 related articles for article (PubMed ID: 10454658)

  • 1. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C
    J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M; Mukherjee P; Biswas R
    Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable contraceptives: underused and undervalued?
    Parker C
    Prof Care Mother Child; 1997; 7(4):95-7. PubMed ID: 9348967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF
    IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable contraceptives: how safe are they?
    Initiatives Popul; 1979; 5(4):2-10. PubMed ID: 12338524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the use of depo-medroxyprogesterone acetate in a Nigerian population.
    Falase EA; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1988 Dec; 17(4):209-13. PubMed ID: 2854367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.